Cargando…
Whole Body Ip6k1 Deletion Protects Mice from Age-Induced Weight Gain, Insulin Resistance and Metabolic Dysfunction
(1) Background: We previously demonstrated that disruption of IP6K1 improves metabolism, protecting mice from high-fat diet-induced obesity, insulin resistance, and non-alcoholic fatty liver disease and steatohepatitis. Age-induced metabolic dysfunction is a major risk factor for metabolic diseases....
Autores principales: | Ghoshal, Sarbani, Mukherjee, Sandip, Chakraborty, Molee, Msengi, Eliwaza Naomi, Haubner, Jake, Chakraborty, Anutosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878859/ https://www.ncbi.nlm.nih.gov/pubmed/35216174 http://dx.doi.org/10.3390/ijms23042059 |
Ejemplares similares
-
Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis
por: Mukherjee, Sandip, et al.
Publicado: (2021) -
Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain
por: Zhu, Qingzhang, et al.
Publicado: (2016) -
The IP6K Inhibitor LI-2242 Ameliorates Diet-Induced Obesity, Hyperglycemia, and Hepatic Steatosis in Mice by Improving Cell Metabolism and Insulin Signaling
por: Mukherjee, Sandip, et al.
Publicado: (2023) -
Ube4A maintains metabolic homeostasis and facilitates insulin signaling in vivo
por: Mukherjee, Sandip, et al.
Publicado: (2023) -
Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases
por: Mukherjee, Sandip, et al.
Publicado: (2020)